(Nasdaq: KLTR), the Agentic Digital Experience company, today announced the open-source release of a suite of AI agent skills ...

ChatGPT subscribers can now run OpenClaw's AI agents via GPT-5.4 for $23/mo. Anthropic blocked Claude. OpenAI and Anthropic made opposite bets on the same product.

To put that theory into practice, I teamed up with my friend Jared Bauman, built an AI-powered poem generator, and released ...

Samir Kapadia, Managing Principal at Vogel Group, says the first issue that needs to be addressed on the Strait of Hormuz is whether Iran can make revenue from it, as it wants a 'sanctions shield' to ...

Ozone API provides open banking APIs to iFast Global Bank Ozone API, the global leader in standards-based Open Banking technology, today announced a strategic partnership with iFAST Global Bank, the ...

Disney‘s much heralded $1 billion investment in OpenAI is over as the Sam Altman-led tech giant said Tuesday that it will be shuttering its stand-alone Sora text-to-video app. “The deal is not moving ...

The start-up said it would discontinue Sora just three months after signing a multiyear deal to bring Disney characters to the service. By Cade Metz Reporting from San Francisco OpenAI is shutting ...

American Petroleum Institute CEO Mike Sommers discusses the national average price of diesel at $5.28 per gallon, oil prices and the impact of the Strait of Hormuz functionally being closed on 'Varney ...

Generate runnable pytest API tests instantly from an OpenAPI specification. Paste a spec URL and automatically generate test code with JSON schema validation, parameter generation, and example ...

Ortelius Advisors, L.P. (“Ortelius” or “we”) believes that Surgery Partners, Inc. (“Surgery” or the “Company”) has significant upside potential, based on its high-quality assets, favorable industry ...

Open Builder is an AI-driven web app generator that runs entirely in the browser. Simply describe the application you want to build in natural language, and the AI will automatically create, modify, ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...